Closure Medical Vascular Sealant Will Challenge Baxter, CryoLife Products
This article was originally published in The Gray Sheet
Executive Summary
Closure Medical plans to focus 2004 R&D efforts on preparing and completing a definitive clinical trial for a vascular sealant device that the firm will promote as a stronger, easier-to-use alternative to Baxter's Tisseel and CryoLife's BioGlue